Overcoming everyday challenges in Alzheimer’s

Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease (Ebixa SmPC)

Efficacy in AD

Read more.

Safety and tolerability

Read more.

Mode of action

Read more.

Once-Daily administration

Read more.

Published: 02/06/2006   Last updated: 31/01/2012
 
Related information

www.irecover.com www.cipralex.com www.azilect.eu www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us